Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
VYNE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -65.7%
VYNE
VYNE Therapeutics Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
therapeutics
after
trading
rose
announced
market
gained
million
stocks
results
reported
nyse
vyn201
inhibitor
data
billion
2023
trial
phase
StonvexStonvexStonvexStonvex